We're sorry but this app doesn't work properly without JavaScript enabled. Please enable it to continue. September 23, 2025 - MeDirect Bank Malta

Outperformance Matters – Episode 3 – AI: Hype vs Reality

The latest episode of Outperformance Matters, the Blue Whale Capital podcast features a detailed discussion on AI, a topic which has been at the forefront of investors’ minds for many months now.

Clearly those investors who have not had an allocation to AI have found it very hard to outperform the market but what might happen next? The conversation goes on to look at how Blue Whale is approaching this sector and highlight some points that investors need to look out for.

While huge amounts are being spent on AI, we are still in the early stages so it’s important to understand who is on the receiving end of this spending when thinking about which companies to invest in. While some areas of AI, such as the use of LLMs in software have already shown their worth, other areas still have a long way to go.

What is certain is that AI will change the world and companies with huge data sets have a significant advantaged. Personalised holidays that are fully managed by an AI agent, AI driven drug discovery and personalised medicine are two areas that have huge potential for example. But companies in these sectors, and others, need to act fast as within five years they may find that competitors with the right AI solutions have overtaken them.

Looking ahead, investors need to keep their eyes open on developments and to scan the globe as China, Taiwan and other Asian markets continue to play an important role in the development of the sector.

This week’s Myth Busting segment looks at the idea that share price volatility is a risk. The fact is that prices will go up and down and that what investors should really be paying attention to are the long term fundamentals and cyclical changes which can result in the real loss of capital.


Blue Whale Key Risks & Disclaimers:

The Blue Whale Growth Fund was launched in September 2020. All references to actions before this date relate to the LF Blue Whale Growth Fund.  Information on the LF Blue Whale Growth Fund is provided for comparison purposes only; it is a UK UCITS which is not registered for sale in nor is it promoted to investors in the EEA.  Whilst the investment objectives and charges are not identical, both funds are run on the same investment process.

Please note that the information provided in this article is not to be construed as advice and any views we express on holdings do not constitute investment recommendations and must not be viewed as such. If you are unsure as to the suitability of an investment for your circumstances, please seek independent financial advice. Investments can go down in value as well as up so you may get back less than you invested. Your capital is at risk. Past performance is not a guide to future performance. Blue Whale Capital LLP is authorised and regulated by the UK Financial Conduct Authority.

There are significant risks associated with investment in the Funds referred to herein. Investment in the Funds is intended for investors who understand and can accept the risks associated with such an investment including potentially a substantial or complete loss of their investment.

Past performance is not a guide to future performance. The value of investments and any income derived from them can go down as well as up and the value of your investment may be volatile and be subject to sudden and substantial falls.

Investment in a Fund with exposure to emerging markets involves risk factors and special considerations which may not be typically associated with investing in more developed markets. Political or economic change and instability may be more likely to occur and have a greater effect on the economies and markets of emerging countries. Adverse government policies, taxation, restrictions on foreign investment and on currency convertibility and repatriation, currency fluctuations and other developments in the laws and regulations of emerging countries in which investment may be made, including expropriation, nationalisation or other confiscation could result in loss to the Fund.

Income from investments may fluctuate. Changes in rates of exchange may have an adverse effect on the value, price or income of investments. Fund charges may be applied in whole or part to capital, which may result in capital erosion. The Authorised Corporate Director may apply a dilution adjustment as detailed in the Prospectus. The Fund is not traded on an exchange or recognised market.

The foregoing list of risk factors is not complete, and reference should be made to the Fund’s Prospectus and KID.


MeDirect Disclaimers:

This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed are intended for retail clients, however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in these products you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. The performance figures quoted are only estimates and may not be a reliable indicator of future performance of this investment. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

MeDirect Bank (Malta) plc, company registration number C34125, is regulated by the Malta Financial Services Authority and is licensed to undertake the business of investment services under the Investment Services Act (Cap. 370).MeDirect Bank (Malta) plc, The Centre, Tigné Point, Sliema, TPO 0001, Malta.

Foreign investment strengthens Malta’s banking sector

Article published by MaltaInvest.mt

A €60 million investment from Banka CREDITAS ‘invigorates’ MeDirect’s ability to compete with traditional banks, says CEO.

The acquisition of MeDirect by Czech-based Banka CREDITAS delivers one of the most significant recent foreign investments into Malta’s financial services sector, bolstering the capital base of the country’s first digital bank.

The €60 million capital injection from Banka CREDITAS marks a pivotal moment for MeDirect, which has grown from its Maltese roots into a pan-European challenger bank with more than 160,000 customers and over €6 billion in assets.

For Malta, this investment underscores the country’s attractiveness as a hub for international financial services, reinforcing its position as a jurisdiction where foreign players see value in building long-term partnerships.

A sign of confidence in Malta

MeDirect CEO Jean-Claude Maher tells MaltaInvest.mt that the acquisition brings not only capital but also international credibility. “The acquisition of MeDirect by Banka CREDITAS has injected €60 million into our business. This is the financial firepower we needed to really push forward with our existing strategy to be the main challenger bank in the markets we operate in,” he says.

He reiterates that the bank will remain firmly anchored in Malta. “I reiterate the fact that MeDirect will remain a Maltese bank, headquartered in Malta, and committed to serving the Maltese economy,” he notes.

A boost to competition

The arrival of a new shareholder with deep resources is expected to invigorate competition within the local banking market, traditionally dominated by large incumbents.

According to Mr Maher, “the €60 million investment from Banka CREDITAS invigorates our ability to compete with the traditional banks in Malta. With the new resources available, we will be able to make sure that many more people in Malta hear about MeDirect and understand that our combination of a market leading digital banking platform, world class IT infrastructure and personalised support is a powerful one.”

Expanding Malta’s financial ecosystem

The transaction, which was finalised after approval from the European Central Bank, highlights the role of Malta’s regulatory framework in facilitating cross-border deals that strengthen the local economy.

While the acquisition is not expected to immediately expand MeDirect’s geographical reach, it provides the bank with greater resources to scale up within its current footprint. “Our shared focus on innovation and customer centricity gives us an incredible opportunity to consolidate the strength of both banks and grow our collective footprint in existing markets,” Mr Maher explains.

Malta’s evolving role in European banking

Founded in Malta in 2004, MeDirect has steadily transformed into a pan-European challenger bank. With this latest foreign investment, the bank’s position as a key financial player in Malta is further reinforced, while also enhancing the country’s standing within the wider European banking landscape.

For Malta, the deal not only brings additional capital into its financial sector but also reaffirms the jurisdiction’s appeal to international investors seeking exposure to the European Union’s regulated banking market.

MeDirect Bank (Malta) plc, company registration number C34125, is regulated by the Malta Financial Services Authority and is licensed to undertake the business of banking in terms of the Banking Act (Cap. 371) and investment services under the Investment Services Act (Cap. 370).

MeDirect Bank (Malta) plc, The Centre, Tigné Point, Sliema, TPO 0001, Malta.

€60 million boost: MeDirect CEO outlines post-acquisition growth strategy

Article published by MaltaCEOs

A €60 million capital injection from Banka CREDITAS will accelerate, rather than change, the bank’s challenger strategy.

MeDirect Group CEO Jean-Claude Maher tells MaltaCEOs.mt that the €60 million capital injection from Banka CREDITAS will accelerate, rather than change, the bank’s challenger strategy in Malta and across Europe.

MeDirect Group’s acquisition by Czech-based Banka CREDITAS marks the beginning of a new growth chapter for Malta’s first digital bank. The deal saw Banka CREDITAS acquire all shares of MDB Group Limited – the parent company of MeDirect Bank (Malta) plc – from Medifin Finance Limited.

The transaction comes with a €60 million capital injection, which CEO Mr Maher describes as “the financial firepower we needed to really push forward with our existing strategy to be the main challenger bank in the markets we operate in.”

Mr Maher stresses that the acquisition does not signal a shift in direction, but rather a strengthening of the bank’s existing business model. “In other words, we will be accelerating our strategy, not changing it,” he says.

Being a challenger bank, he explains, means using MeDirect’s “robust open architecture infrastructure” and focus on customer centricity to deliver a fully-fledged suite of retail and corporate banking services.

“In Malta, we will also continue to combine our digital infrastructure with the personalised support we offer through our advisory and branch services,” he adds.

Focus on corporate banking

The CEO pointed to corporate banking as the bank’s immediate priority in Malta. MeDirect already has a reputation for its corporate digital banking platform on the transactional side, and the plan is to “successively broaden our suite of products and services, ensuring these are tailored towards the needs of that client segment.”

He highlighted that MeDirect’s track record – from its investment platform to its home loan service and retail banking operations – demonstrates its ability to quickly bring products to market. “Joining Banka CREDITAS, which has the same challenger bank DNA, gives us the ability to do more,” he says.

Continuity for Maltese customers

Despite the change in ownership, MeDirect’s identity will remain intact. “MeDirect will remain a Maltese bank, headquartered in Malta, and committed to serving the Maltese economy,” Mr Maher underlines.

He emphasises that the bank already operates on a highly secure and resilient open architecture platform, which enables it to launch new products quickly and adapt to customer needs. With Banka CREDITAS’s investment, the bank can now “fulfil this platform’s potential, expanding our product offering while retaining the very highest levels of security and reliability.”

Strength to compete with traditional banks

According to Mr Maher, the €60 million investment invigorates MeDirect’s ability to compete with Malta’s larger, more traditional players. “There are already many MeDirect clients who know what our platform can offer, whether it’s investing, home loans, or corporate onboarding and credit underwriting,” he says.

“With the new resources available, we will be able to make sure that many more people in Malta hear about MeDirect and understand that our combination of a market leading digital banking platform, world class IT infrastructure and personalised support is a powerful one.”

MeDirect, founded in Malta in 2004, has grown into a pan-European digital bank serving more than 160,000 customers and managing over €6 billion in assets. Beyond its home market, it has established itself in Belgium, where it operates purely digitally.

While there are no immediate plans to enter new geographies, Mr Maher sees significant scope to grow market share in existing markets, thanks to the combined strength of MeDirect and Banka CREDITAS. “Our shared focus on innovation and customer centricity gives us an incredible opportunity to consolidate the strength of both banks and grow our collective footprint,” he says.

MeDirect Bank (Malta) plc, company registration number C34125, is regulated by the Malta Financial Services Authority and is licensed to undertake the business of banking in terms of the Banking Act (Cap. 371) and investment services under the Investment Services Act (Cap. 370).

MeDirect Bank (Malta) plc, The Centre, Tigné Point, Sliema, TPO 0001, Malta.

BlackRock Commentary: Sticking with granular views in Europe

Wei Li – Global Chief Investment Strategist of BlackRock Investment Institute together with Roelof Salomons – Chief Investment Strategist for the Netherlands, Bruno Rovelli – Chief Investment Strategist for Italy and Simon Blundell – Head of European Fundamental Fixed Income, all forming part of the BlackRock Investment Institute share their insights on global economy, markets and geopolitics. Their views are theirs alone and are not intended to be construed as investment advice.

Key Points

Bright spots in Europe: Our U.S. equity overweight has played out this year – and so have other preferences in Europe that we stick with, including credit and financial stocks.

Market backdrop: U.S. stocks surged to all-time highs and U.S. 10-year Treasury yields edged up after the Federal Reserve resumed rate cuts. Gold also surged to new highs.

Week ahead: We eye U.S. PCE inflation data. Cooling services inflation contributed to the Fed’s decision to cut rates. We look to see if it persists or picks back up.

The Federal Reserve’s restart of policy rate cuts supports our tactical upgrade to long-term U.S. Treasuries and risk-on stance. Yet opportunities abound outside the U.S. A weaker U.S. dollar has been a boon to international markets, and we eye opportunities in Europe for dollar-based investors. We still prefer euro area credit over the U.S. but close our preference for peripheral over core government bonds. We also still favor financials and industrials stocks, and Spain at the country level.

Our core risk stance has leaned on U.S. equities and the AI theme. Yet a weaker U.S. dollar has unlocked international opportunities for dollar-based investors – both in emerging markets and in Europe. Higher U.S. policy rates keep the gap with euro area rates wide, even after the Fed resumed rate cuts. The European Central Bank is set to hold rates at 2%, well below the Fed’s 4.00-4.25% even if it cuts more. That large interest rate differential benefits U.S. investors. Why? Hedging foreign bonds back into U.S. dollars captures this differential and boosts the income they offer. That raises the income on offer in Europe even above the U.S. – euro investment grade credit yields are near 6% – and contributed to our relative preference for fixed income in Europe. See the chart. Yet granularity is key. We stay neutral euro area government bonds overall and keep favoring credit and select equity sectors.

We close our long-held relative preference for peripheral euro area government bonds over the core. Stronger growth in Spain and Greece and relative political stability in Italy had driven yields down relative to French and German yields more than a decade after the region’s debt crisis. But yields and spreads now reflect that stability, in our view. France is facing political gridlock stymying efforts to trim debt, while Germany has embraced looser fiscal policy this year. But we think a lot of the risks in French bonds are priced in with its 10-year yields above those in Spain by the most since the euro was launched.

Credit over government bonds, Europe over U.S.

We prefer credit to government bonds globally and Europe over the U.S. Globally, the corporate sector has demonstrated greater creditworthiness than the public sector. Yes, defaults have increased since the pandemic, but the stress is concentrated among smaller issuers rather than larger companies, according to Moody’s. Wider spreads meant European credit offered investors better compensation for risk than U.S. credit. That view has since paid off: spreads in Europe have tightened sharply relative to the U.S. European high yield credit outperformed European government bonds by almost 3% year-to-date, whereas U.S. high-yield credit has outperformed U.S. Treasuries by less than 2%, Bloomberg data show.

In equities, Europe’s outperformance over the U.S. peaked in late March – but we still see granular opportunities we have liked since the start of 2025. Selectivity is essential. We favored three European sectors that have outperformed the U.S.: industrials (21% return, LSEG data show), utilities (19%) and financials (32%). European financials still benefit from healthy balance sheets, a stronger fee business and improving profitability. Industrials are getting a boost from Europe’s focus on defense, Germany’s infrastructure push and the AI buildout. By country, we prefer Spanish equities where these sectors are well represented. Another plus? Spanish equities have greater exposure to emerging markets, especially Latin America, that can benefit from easier Fed policy and potential further U.S. dollar weakness. We think relative valuations still do not reflect the country’s stronger economic growth and earnings compared with the rest of Europe – and see further upside.

Our bottom line

U.S. rate cuts support our risk-on stance, but we see ample – if select – opportunity in Europe. We favor EU credit and the income boost from currency hedging, as well as equity sectors including financials, industrials and utilities.

Market backdrop

U.S. stocks pushed to new all-time highs last week, with tech shares again leading the way and taking the S&P 500’s gains to 13% for the year. Gold prices also hit record peaks to take gains to 40% this year. U.S. 10-year Treasury yields edged up to around 4.15% after the Fed resumed rate cuts but signaled fewer cuts ahead than the market is pricing in. We think a further softening of the labor market will be key for the Fed to keep cutting rates.

We’re tracking U.S. August PCE this week after headline CPI inflation met expectations and jobless claims ticked higher. Tariffs are reviving goods inflation just as services inflation is proving sticky. But the recent easing in core services inflation could be more than temporary if the labor market cools further. That makes understanding the drivers of a weaker labor market and future productivity key to gauging the outlook for inflation and Federal Reserve policy.

Week Ahead

Sep. 23: Global flash PMIs

Sep. 25: U.S. durable goods

Sep. 26: U.S. PCE


BlackRock’s Key risks & Disclaimers:

This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of 22nd September, 2025 and may change. The information and opinions are derived from proprietary and non-proprietary sources deemed by BlackRock to be reliable, are not necessarily all-inclusive and are not guaranteed as to accuracy. As such, no warranty of accuracy or reliability is given and no responsibility arising in any other way for errors and omissions (including responsibility to any person by reason of negligence) is accepted by BlackRock, its officers, employees or agents. This material may contain ’forward looking’ information that is not purely historical in nature. Such information may include, among other things, projections and forecasts. There is no guarantee that any forecasts made will come to pass. Reliance upon information in this material is at the sole discretion of the reader.

The information provided here is neither tax nor legal advice. Investors should speak to their tax professional for specific information regarding their tax situation. Investment involves risk including possible loss of principal. International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation, and the possibility of substantial volatility due to adverse political, economic or other developments. These risks are often heightened for investments in emerging/developing markets or smaller capital markets.

Issued by BlackRock Investment Management (UK) Limited, authorized and regulated by the Financial Conduct Authority. Registered office: 12 Throgmorton Avenue, London, EC2N 2DL.


MeDirect Disclaimers:

This information has been accurately reproduced, as received from  BlackRock Investment Management (UK) Limited. No information has been omitted which would render the reproduced information inaccurate or misleading. This information is being distributed by MeDirect Bank (Malta) plc to its customers. The information contained in this document is for general information purposes only and is not intended to provide legal or other professional advice nor does it commit MeDirect Bank (Malta) plc to any obligation whatsoever. The information available in this document is not intended to be a suggestion, recommendation or solicitation to buy, hold or sell, any securities and is not guaranteed as to accuracy or completeness.

The financial instruments discussed in the document is intended for retail clients however, it may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.

If you invest in this product you may lose some or all of the money you invest. The value of your investment may go down as well as up. A commission or sales fee may be charged at the time of the initial purchase for an investment. Any income you get from this investment may go down as well as up. This product may be affected by changes in currency exchange rate movements thereby affecting your investment return therefrom. The performance figures quoted refer to the past and past performance is not a guarantee of future performance or a reliable guide to future performance. Any decision to invest in a mutual fund should always be based upon the details contained in the Prospectus and Key Information Document (KID), which may be obtained from MeDirect Bank (Malta) plc.

You are leaving medirect.com.mt

Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.

 

Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.

Login

We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.

For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.